在非小细胞肺癌中Trop-2表达
Peiwen Kuo1, Emon Elboudwarej1, Marianna Zavodovskaya1
1Gilead Sciences, Inc., Foster City, California, United States of America.
PloS one
|April 15, 2025
概括
热囊细胞表面抗原2 (Trop-2) 在大多数非小细胞肺癌 (NSCLC) 中表达高. 这种广泛的蛋白质表达支持使用Trop-2向抗体-药物联合体 (ADC) 治疗NSCLC.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 热原体细胞表面抗原2 (Trop-2) 在非小细胞肺癌 (NSCLC) 中表达高,使其成为抗体-药物合物 (ADC) 的有前途标.
- 了解Trop-2在蛋白质水平上的表达对于评估Trop-2ADC的疗效至关重要,但目前的知识有限.
研究的目的:
- 在各种NSCLC数据集中,在mRNA和蛋白质水平上全面描述Trop-2表达.
- 研究Trop-2表达与临床病理特征,遗传变化和NSCLC患者预后之间的关系.
主要方法:
- 使用癌症基因组图谱 (TCGA) 和两个独立样本集对Trop-2 mRNA,突变和蛋白质表达的分析.
- 利用免疫组织化学 (SP295克隆) 和RNA测序用于蛋白质和RNA表达特征.
- 与临床数据相关的Trop-2表达,包括组织学,基线特征和生存结果.
主要成果:
- 在NSCLC中Trop-2的表达很高,在腺癌和状细胞癌中观察到类似的表达模式.
- Trop-2表达独立于患者的年龄,性别,瘤阶段和临床相关的遗传改变.
- 在分析的样本集中,在82%至90%的NSCLC病例中检测到蛋白质水平Trop-2表达.
结论:
- 高Trop-2表达是NSCLC亚型的共同特征,与预后因素或特定驱动突变无关.
- 在NSCLC中广泛和一致的Trop-2蛋白表达支持其作为抗体-药物合物的标的广泛适用性.
更多相关视频
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.7K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.5K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
03:18Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K